Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AK112”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06938321
What this trial is testing

AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Akeso 135
Testing effectiveness (Phase 2)Looking for participantsNCT06491472
What this trial is testing

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Post-approval studies (Phase 4)Looking for participantsNCT06930573
What this trial is testing

AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC
The First Affiliated Hospital of Zhengzhou University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05689853
What this trial is testing

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Akeso 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT05382442
What this trial is testing

AK112 With or Without AK117 in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Akeso 254
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06904300
What this trial is testing

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

Who this might be right for
Gastric (Cardia, Body) Cancer
Sun Yat-sen University 110
Testing effectiveness (Phase 2)Looking for participantsNCT06196697
What this trial is testing

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Harbin Medical University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07158840
What this trial is testing

AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment

Who this might be right for
Non-Small Cell Lung Cancer
Akeso 60
Testing effectiveness (Phase 2)Looking for participantsNCT06560112
What this trial is testing

An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Akeso 172
Testing effectiveness (Phase 2)Looking for participantsNCT07590531
What this trial is testing

AMT-116 in Combination With AK112 in Patients With Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)
Multitude Therapeutics Inc. 118
Large-scale testing (Phase 3)Active Not RecruitingNCT05840016
What this trial is testing

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced Squamous Non Small Cell Lung Cancer
Akeso 532
Early research (Phase 1)Study completedNCT05116007
What this trial is testing

Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Akeso 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06790212
What this trial is testing

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 168
Large-scale testing (Phase 3)Active Not RecruitingNCT05184712
What this trial is testing

Phase 3 Clinical Study of AK112 for NSCLC Patients

Who this might be right for
Non-Squamous Non-small Cell Lung Cancer
Akeso 322
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07636772
What this trial is testing

A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma (UC)
Akeso 132
Testing effectiveness (Phase 2)Looking for participantsNCT06402435
What this trial is testing

SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer

Who this might be right for
Breast Cancer
Hubei Cancer Hospital 50
Early research (Phase 1)Not Yet RecruitingNCT07650825
What this trial is testing

OVV-01 Intravenous and Intratumoral Injection Combined With AK112 for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT07114315
What this trial is testing

AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Akeso 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT04736823
What this trial is testing

A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC

Who this might be right for
NSCLC
Akeso 265
Not applicableEnrolling By InvitationNCT06936488
What this trial is testing

A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer

Who this might be right for
MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients
Huai'an First People's Hospital 35
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation